CO2レーザーによるトランスミオカルディアルレーザーリバスクュラライゼーションの5年後に持続したアンギナ緩和
K A Horvath1, S F Aranki, L H Cohn
1Northwestern University Medical School, Chicago, Illinois, USA. khorvath@nmh.org
Circulation
|September 25, 2001
まとめ
トランスミオカルディアルレーザー再血管化は,少なくとも5年間持続する重度のアンギナに対して,長期的に有意な緩和をもたらします. この手順は,アンギナクラスと患者の生活の質の持続的な改善を提供します.
科学分野:
- 心血管外科手術についてです.
- 介入性心臓病学 介入性心臓病学
- 医療技術 医療技術について
背景:
- トランスミオカルディアルレーザー再血管化は,短期的なアンギナ緩和をもたらすが,長期的な有効性は不明である.
- 長期的な成果を評価することは,TMRの持続的な利益を理解するために不可欠です.
- TMR後7年までの将来的なデータ収集は,耐久性を評価するために不可欠です.
研究 の 目的:
- 重度の胸痛に対するトランスミオカルディアルレーザー再血管化 (TMR) の長期的な有効性を評価する.
- 術後5年を超えてのアンギナ症状緩和の持続性を評価する.
- 持続的な改善を確認するには,アングイナクラスとシアトル・アングイナアンケート (SAQ) のスコアを使用します.
主な方法:
- 重症で耐性アンギナを持つ78人の患者にCO2レーザーTMRを施しました.
- 患者は前向きに最大7年間追跡され,アンギナ症状はアンギナクラスとSAQによって評価されました.
- 術前の特徴には,不安定なアンギナ,以前の心筋梗塞,および以前の再血管化処置の高い割合が含まれていました.
主要な成果:
- 長期フォローアップ (平均5年,最大7年) では,平均アンギナクラス (3.7~1.6) の有意な改善が見られた.
- 胸痛の緩和は持続しており,TMR後1年から5年までのクラスの有意な変化はありませんでした.
- 患者の68%が長期にわたるアンギナ緩和 (≥2クラス減少) を経験し,SAQスコアはベースラインより170%改善しました.
結論:
- トランスミオカルディアンレーザー再血管化は,重度の心筋梗塞に対して持続的な長期的な有効性を示しています.
- 障害性アンギナに対する唯一の治療法としてTMRの効果は,少なくとも5年間持続します.
- TMRは,アンギナ症状の有意かつ持続的な緩和を提供し,患者の生活の質を改善します.
関連する概念動画
01:28Esophageal Varices-II: Clinical Features and Management
884
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
884
01:26Mitral Stenosis III: Medical Management
535
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
01:30Acute Coronary Syndrome III: Diagnostic Studies
495
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
01:27Angina II: Classification
709
Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
709
01:29Angina III: Clinical Manifestations and Assessment
481
Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
481
01:26Angina IV: Management
493
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
493